CUVL
Clinuvel Pharmaceuticals Ltd.
CUVL
Clinuvel Pharmaceuticals Ltd.
Clinuvel Pharmaceuticals Limited is a profitable orphan-drug biotech with SCENESSE driving over 90% of revenue and exceptional margins. Despite flat growth in FY2026, CUVL maintains a strong balance s
MELBOURNE, Australia and NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- CLINUVEL PHARMACEUTICALS LTD (ASX: CUV | Nasdaq: CUVL) today announced a strategic reorganisation of its operations and workforce,